561 related articles for article (PubMed ID: 27930095)
1. Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma.
Jayaram S; Gupta MK; Raju R; Gautam P; Sirdeshmukh R
OMICS; 2016 Dec; 20(12):736-746. PubMed ID: 27930095
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation.
Tripathi PH; Akhtar J; Arora J; Saran RK; Mishra N; Polisetty RV; Sirdeshmukh R; Gautam P
BMC Cancer; 2022 Feb; 22(1):133. PubMed ID: 35109816
[TBL] [Abstract][Full Text] [Related]
3. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
4. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
5. Integrative multi-omics characterization reveals sex differences in glioblastoma.
Jang B; Yoon D; Lee JY; Kim J; Hong J; Koo H; Sa JK
Biol Sex Differ; 2024 Mar; 15(1):23. PubMed ID: 38491408
[TBL] [Abstract][Full Text] [Related]
6. Towards developing biomarkers for glioblastoma multiforme: a proteomics view.
Jayaram S; Gupta MK; Polisetty RV; Cho WC; Sirdeshmukh R
Expert Rev Proteomics; 2014 Oct; 11(5):621-39. PubMed ID: 25115191
[TBL] [Abstract][Full Text] [Related]
7. Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.
Mathew LK; Huangyang P; Mucaj V; Lee SS; Skuli N; Eisinger-Mathason TS; Biju K; Li B; Venneti S; Lal P; Lathia JD; Rich JN; Keith B; Simon MC
Sci Signal; 2015 May; 8(375):ra42. PubMed ID: 25943352
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of transcriptome and proteome profiles in primary and recurrent glioblastoma.
Zhang J; Wang G; Yan B; Yang G; Yang Q; Hu Y; Guo J; Zhao N; Wang L; Wang H
Proteomics Clin Appl; 2024 May; 18(3):e2200085. PubMed ID: 38037768
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
Brown KE; Chagoya G; Kwatra SG; Yen T; Keir ST; Cooter M; Hoadley KA; Rasheed A; Lipp ES; Mclendon R; Ali-Osman F; Bigner DD; Sampson JH; Kwatra MM
J Neurochem; 2015 Jun; 133(5):730-8. PubMed ID: 25598002
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic and Proteomic Data Integration and Two-Dimensional Molecular Maps with Regulatory and Functional Linkages: Application to Cell Proliferation and Invasion Networks in Glioblastoma.
Gupta MK; Jayaram S; Reddy DN; Polisetty RV; Sirdeshmukh R
J Proteome Res; 2015 Dec; 14(12):5017-27. PubMed ID: 26464075
[TBL] [Abstract][Full Text] [Related]
11. MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
Liu YS; Lin HY; Lai SW; Huang CY; Huang BR; Chen PY; Wei KC; Lu DY
Oncogene; 2017 Aug; 36(35):5006-5022. PubMed ID: 28459461
[TBL] [Abstract][Full Text] [Related]
12. A Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex Disease.
Xu C; Zhang JG; Lin D; Zhang L; Shen H; Deng HW
G3 (Bethesda); 2017 Jul; 7(7):2271-2279. PubMed ID: 28500050
[TBL] [Abstract][Full Text] [Related]
13. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib.
Halatsch ME; Löw S; Hielscher T; Schmidt U; Unterberg A; Vougioukas VI
Anticancer Res; 2008; 28(6A):3725-8. PubMed ID: 19189656
[TBL] [Abstract][Full Text] [Related]
15. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
[TBL] [Abstract][Full Text] [Related]
16. Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme.
Bernal Rubio YL; González-Reymúndez A; Wu KH; Griguer CE; Steibel JP; de Los Campos G; Doseff A; Gallo K; Vazquez AI
G3 (Bethesda); 2018 Nov; 8(11):3627-3636. PubMed ID: 30228192
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
Brennan C; Momota H; Hambardzumyan D; Ozawa T; Tandon A; Pedraza A; Holland E
PLoS One; 2009 Nov; 4(11):e7752. PubMed ID: 19915670
[TBL] [Abstract][Full Text] [Related]
18. Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.
Walsh AM; Kapoor GS; Buonato JM; Mathew LK; Bi Y; Davuluri RV; Martinez-Lage M; Simon MC; O'Rourke DM; Lazzara MJ
Mol Cancer Res; 2015 Aug; 13(8):1227-37. PubMed ID: 25934697
[TBL] [Abstract][Full Text] [Related]
19. A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.
Wykosky J; Hu J; Gomez GG; Taylor T; Villa GR; Pizzo D; VandenBerg SR; Thorne AH; Chen CC; Mischel PS; Gonias SL; Cavenee WK; Furnari FB
Cancer Res; 2015 Jan; 75(2):394-404. PubMed ID: 25432173
[TBL] [Abstract][Full Text] [Related]
20. The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment.
Guo G; Narayan RN; Horton L; Patel TR; Habib AA
Curr Cancer Drug Targets; 2017; 17(3):297-302. PubMed ID: 28004613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
